Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevate Health vs Kin Meds

Elevate Health
Graded #371

Lower grade

vs+14.400000000000006
Kin Meds
Graded #73

Higher grade

The verdict

Kin Meds takes it — 72.9/100 to 58.5/100.

Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKin Meds +42
32
74
Dose & formulationKin Meds +16
77
93
Clinical oversightElevate Health +5
79
74
Labs & monitoringElevate Health +10
63
53
FulfillmentKin Meds +7
65
72
Contract termsKin Meds +30
25
55
Elevate Health · left barKin Meds · right bar

The numbers

MetricElevate HealthKin Meds
WeighScore58.5/10072.9/100
GradeCC
Scorecard rank#371#73
Semaglutide$299/mo (compounded)$149/mo (brand Wegovy)
Tirzepatide$399/mo (compounded)$149/mo (brand Zepbound)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Elevate Health

Graded #371 · C

Strengths

  • Compounded semaglutide ($299/mo, from $158/mo on 12-month) and tirzepatide ($399/mo, from $248/mo)
  • Also offers brand-name Zepbound (tirzepatide) plus NAD+, B12, and glutathione add-ons
  • All supplies included; Affirm/Klarna payment plans available
  • Full refund if you are not approved
  • 35,000+ patients served

Where it loses points

  • Month-to-month pricing is high ($299 sema / $399 tirz); the low rates require a 12-month commitment
  • Pharmacy partner and prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • No standalone Terms of Service page (only Privacy, HIPAA, and a safety-information page)
Kin Meds

Graded #73 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard